Skip to main content
SpringerLink
Log in

Diseases Mimicking Constrictive Pericarditis: Salient Features and Novel Strategies of Management

  • Chapter
  • First Online:
Surgical Treatment of Chronic Constrictive Pericarditis

  • 50 Accesses

Abstract

This chapter highlights the nuances encountered in establishing the diagnosis of chronic constrictive pericarditis and various diseases mimicking constrictive pericarditis. A stepwise algorithm based on clinical picture, new echocardiographic techniques, and multimodality imaging studies for differentiating the allied disease entities and novel management strategies alongwith citations have been discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Akinwusi PO, Odeyemi AO. The changing pattern of endomyocardial fibrosis in South-West Nigeria. Clin Med Insights Cardiol. 2012;6:163–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W, ESC Scientific Document Group. ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;2015(36):2921–64.

    Article  Google Scholar 

  3. Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther. 2004;20:867–73.

    Article  PubMed  CAS  Google Scholar 

  4. Balakrishnan KG, Jaiswal PK, Tharakan JM, Venkitachalam CG, Ghosh MK. Clinical course of patients in Kerala. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardialfibrosis. New Delhi: Oxford University Press; 1993. p. 20–8.

    Google Scholar 

  5. Budd G. Diseases of the liver. Philadelphia: Blanchard and Lea; 1857. p. 194–6.

    Google Scholar 

  6. Budd G. On diseases of the liver. London: John Churchill; 1845. p. 146.

    Google Scholar 

  7. Bertog SC, Thambidorai SK, Parakh K, Schoenhagen P, Ozduran V, Houghtaling PL, Lytle BW, Blackstone EH, Lauer MS, Klein AL. Constrictive pericarditis: aetiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol. 2004;43:1445–52.

    Article  PubMed  Google Scholar 

  8. Balakrishnan KG, Sapru RP, Venkitachalam CG, Sasidharan K. Endocardiographic features in endomyocardial fibrosis. In: Sapru RP, editor. Endomyocardial fibrosis in India. New Delhi: Indian Council of Medical Research; 1983. p. 121–8.

    Google Scholar 

  9. Bertrand E. Natural history and current status in Ivory Coast. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. New Delhi: Oxford University Press; 1993. p. 55–63.

    Google Scholar 

  10. Balakrishnan KG, Sapru RP, Venkitachalam CG, Sasidharan K. Haemodynamic features in endomyocardial fibrosis. In: Sapru RP, editor. Endomyocardial fibrosis in India. New Delhi: Indian Council of Medical Research; 1983. p. 57–63.

    Google Scholar 

  11. Benson MD, Dasgupta NR. Amyloid cardiomyopathy. J Am Coll Cardiol. 2016;68(1):25–8.

    Article  PubMed  Google Scholar 

  12. Banka VS, Agarwal JB, Bodenheimer MM, Helfant RH. Interventricular septal motion: biventricular angiographic assessment of its relative contribution to left and right ventricular contraction. Circulation. 1981;64:992–6.

    Article  PubMed  CAS  Google Scholar 

  13. Bennett SJ, Huster GA, Baker SL, et al. Characterization of the precipitant of hospitalization for heart failure decompensation. Am J Crit Care. 1998;7:168e74.

    Article  Google Scholar 

  14. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1304–23.

    Article  Google Scholar 

  15. Bacon BR, Adams PC, Kowdley KT, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328–43.

    Article  PubMed  Google Scholar 

  16. Balian A, Valla D, Naveau S, et al. Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state. J Hepatol. 1998;28:723–6.

    Article  PubMed  CAS  Google Scholar 

  17. Bernardino ME, Sones PJ. Hepatic radiography. New York: Macmillan; 1984. p. 248.

    Google Scholar 

  18. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet’s disease. Am J Gastroenterol. 1997;92:858–62.

    PubMed  CAS  Google Scholar 

  19. Bernardino ME, Steinberg HV, Pearson TC, et al. Comparison of MAI and angiography in the determination of shunt patency for portal hypertension. Radiology. 1986;158:57–61.

    Article  PubMed  CAS  Google Scholar 

  20. Barrault C, Plessier A, Valla D, Condat B. Nonsurgical treatment of Budd-Chiari syndrome: a review. Gastroenterol Clin Biol. 2004;28:40–9.

    Article  PubMed  Google Scholar 

  21. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med. 2004;351:268–77.

    Article  PubMed  CAS  Google Scholar 

  22. Blokzijl H, de Knegt RJ. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt. Hepatology. 2002;35:1551–2.

    Article  PubMed  Google Scholar 

  23. Banba K, Kusano KF, Nakamura K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm. 2007;4(1):1292–9.

    Article  PubMed  Google Scholar 

  24. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–23.

    Article  PubMed  Google Scholar 

  25. Chelo D, Nguefack F, Mbassi Awa HD, et al. Endomyocardial fibrosis in Sub-Saharan Africa: the geographical origin, socioeconomic status, and dietary habits of cases reported in Yaounde. Cameroon Ann Pediatr Cardiol. 2015;8(3):202–9.

    Article  PubMed  Google Scholar 

  26. Chiari H. Veber die selbstandige Phlebitis Obliterans der Haupstamme der Vanae Hepaticae als Todesursache. Beitr Pathol Arat. 1899;26:1–17.

    Google Scholar 

  27. Castano A, Drachman BM, Judge D, et al. Natural history and therapy ofTTR-cardiac amyloidosis: emerging diseasemodifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev. 2015;20(2):163–78.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Chowdhury UK, Kumari LS. Pericardiectomy for chronic constrictive pericarditis: where are we after 100 years? World J Surg Surg Res. 2018;1:1027–30.

    Google Scholar 

  29. Chowdhury UK, Subramaniam G, Kumar AS, Airan B, Singh R, Talwar S, et al. Pericardiectomy for constrictive pericarditis: clinical, echocardiographic and haemodynamic evaluation of two surgical techniques. Ann Thorac Surg. 2006;81:522–30.

    Article  PubMed  Google Scholar 

  30. Chowdhury UK, Kapoor PM, Rizvi A, Malik V, Seth S, Narang R, et al. Serial semi-invasive haemodynamic assessment following pericardiectomy for chronic constrictive pericarditis. Ann Card Anaesth. 2017;20:169–77.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Chowdhury UK, Seth S, Reddy SM. Pericardiectomy for chronic constrictive pericarditis. J Operat Tech Thorac Cardiovasc Surg. 2008;13:14–25.

    Article  Google Scholar 

  32. Chowdhury UK, Kumari LS, Hasija S. Surgery for chronic constrictive pericarditis, tuberculous pericarditis and effusive-constrictive pericarditis. Cardiological Society of India. Essentials of Postgraduate Cardiology, Evangel Publishers, Invited Chapter 64; 2018. p. 1–10.

    Google Scholar 

  33. Chowdhury UK, Jena JK, Hasija S, Kumari LS. Successful use of intra-aortic balloon counterpulsation for systemic ventricular failure following total pericardiectomy for calcific chronic constrictive pericarditis. World J Ped Cong Heart Surg. 2020;11(4):NP203–6.

    Article  Google Scholar 

  34. Chowdhury UK, Narang R, Malhotra P, Choudhury M, Choudhury A, Singh SP. Indications, timing and techniques of radical pericardiectomy via modified left anterolateral thoracotomy (UKC’s modification) and total pericardiectomy via median sternotomy (Holman and Willett) without cardiopulmonary bypass. J Prac Cardiovasc Sci. 2016;2:17–27.

    Article  Google Scholar 

  35. Chowdhury UK, Patel K, Kumari L, Seth S, Avneesh S, Mishra AK, Kalaivani M, Hasija S. Tissue Doppler imaging-derived mitral and tricuspid annular velocities: non-predictors of operative outcome in patients undergoing pericardiectomy for chronic constrictive pericarditis. J Card Diag Res. 2019;2(2):67–83.

    Google Scholar 

  36. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108:1146–62.

    Article  PubMed  Google Scholar 

  37. Cheng H, Zhao S, Jiang S, Lu M, Yan C, Ling J, Zhang Y, Liu Q, Ma N, Yin G, Jerecic R, He Z. The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. J Cardiovasc Magn Reson. 2011;13:15.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Cheng Z, Zhu K, Tian Z, et al. The findings of electrocardiography in patients with cardiac amyloidosis. Ann Noninvasive Electrocardiol Off Int Soc Holter Noninvasive Electrocardiol Inc. 2013;18(2):157–62.

    Article  Google Scholar 

  39. Connor DH, Somers K, Hutt MSR, Manion WC, D’Arbela PG. Endomyocardial fibrosis (Davies’ disease). Part I. Am Heart J. 1967;74:687–709.

    Article  PubMed  CAS  Google Scholar 

  40. Cockshott WP. Angiocardiography of endomyocardial fibrosis. Br J Radiol. 1965;38:192–200.

    Article  PubMed  CAS  Google Scholar 

  41. Cohen AS. Amyloldosis. N Engl J Med. 1967;277(10):522–30.

    Article  PubMed  CAS  Google Scholar 

  42. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Murray RD, Apperson-Hansen C, Stugaard MPractice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003;42:954–70.

    Article  PubMed  Google Scholar 

  43. Castano A, Drachman BM, Judge D, et al. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease modifying therapies from organ treatment to stabilizer and silencer drugs. Heart Fail Rev. 2015;20(2):163–78.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Clare GC, Troughton RW. Management of constrictive pericarditis in the 21st century. Curr Treat Options Cardiovasc Med. 2007;9:436–42.

    Article  PubMed  Google Scholar 

  45. Colak Y, Karasu Z, Oruc N, et al. Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2006;18:917–20.

    Article  PubMed  Google Scholar 

  46. Campbell DA, Rolles K, Jamieson N, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet. 1988;166:511–8.

    PubMed  Google Scholar 

  47. Cejna M, Peck-Radosavljevic M, Schoder M, et al. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol. 2002;13:193–9.

    Article  PubMed  Google Scholar 

  48. Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC Expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58(8):131–53.

    Article  Google Scholar 

  49. Davies D, Andrews MIJ, Jones JSP. Asbestos-induced pericardial effusion and constrictive pericarditis. Thorax. 1991;46:429–32.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Davies JNP, Ball JD. The pathology of endomyocardial fibrosis in Uganda. Br Heart J. 1955;17:337–59.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Davies JNP. Endomyocardial fibrosis in Uganda. East Afr MedJ. 1948;25:225–35.

    Google Scholar 

  52. Dalton JC, Pearson RJ Jr, White PD. Constrictive pericarditis: a review and long-term follow-up of 78 cases. Ann Intern Med. 1956;45:445–58.

    Article  PubMed  CAS  Google Scholar 

  53. Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest. 1988;94(1):202–3.

    Article  PubMed  CAS  Google Scholar 

  54. Dubost C, Prigent C, Gerbaux A, et al. Surgical treatment of constrictive fibrous endocarditis. Thorac Cardiovasc Surg. 1981;82:585–91.

    Article  CAS  Google Scholar 

  55. Dubrey SW, Burke MM, Hawkins PN, et al. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transpl Off Pub I Int Soc Heart Transpl. 2004;23(10):1142–53.

    Article  Google Scholar 

  56. Dubrey S, Simms RW, Skinner M, Falk RH. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival. Am J Cardiol. 1995;76:739–41.

    Article  PubMed  CAS  Google Scholar 

  57. Darwish-Murad S, Plessier A, Hernandez-Guerra M, et al. A prospective study on 163 pattients with Budd-Chiari syndrome: results from the European Network for Vascular Disorders of the Liver (EN-VIE). J Hepatol. 2007;46:S4.

    Article  Google Scholar 

  58. Dayal S, Pati HP, Pande GK, Sharma MP, Saraya AK. Multilineage hemopoietic stem cell defects in Budd-Chiari syndrome. J Hepatol. 1997;26:293–7.

    Article  PubMed  CAS  Google Scholar 

  59. Deltenre P, Denninger MH, Hillaire S, et al. Factor V Leiden related Budd-Chiari syndrome. Gut. 2001;48:264–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587–91.

    Article  PubMed  CAS  Google Scholar 

  61. Deutch V, Rosenthal T, Adar A, Mozes M. Budd-Chiari syndrome: study of angiographic findings and remarks on aetiology. AJR. 1972;1(16):430–9.

    Article  Google Scholar 

  62. De Ledinghen V, Heresbach D, Fourdan O, et al. Antiinflammatory drugs and variceal bleeding: a case-control study. Gut. 1999;44:270–3.

    Article  PubMed  PubMed Central  Google Scholar 

  63. De BK, Biswas PK, Sen S, et al. Management of the Budd-Chiari syndrome by balloon cavoplasty. Indian J Gastroenterol. 2001;20:151–4.

    PubMed  CAS  Google Scholar 

  64. de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43(1):167–76.

    Article  PubMed  Google Scholar 

  65. Engel PJ, Fowler NO, Tei CW, Shah PM, Driedger HJ, Shabetai R, Harbin AD, Franch RH. M-mode echocardiography in constrictive pericarditis. J Am Coll Cardiol. 1985;6:471–4.

    Article  PubMed  CAS  Google Scholar 

  66. Estep Jerry D, Bhimaraj A, Cordero-Reyes AM, et al. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management. Methodist Debakey Cardiovasc J. 2012;8(3):8–16.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;55:878–84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Falase AO. Endomyocardial fibrosis: aetiological considerations in Nigeria. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardialfibrosis. New Delhi: Oxford University Press; 1993. p. 81–97.

    Google Scholar 

  69. Fontaila M, Chung R, Hawldns PN, et al. Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev. 2015;20(2):133–44.

    Article  Google Scholar 

  70. Furui S, Sawada S, Irie T, et al. Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. Radiology. 1990;176:665–70.

    Article  PubMed  CAS  Google Scholar 

  71. Freeman GL, LeWinter MM. Pericardial adaptations during chronic cardiac dilation in dogs. Circ Res. 1984;54:294–300.

    Article  PubMed  CAS  Google Scholar 

  72. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51:1581–7.

    Article  PubMed  Google Scholar 

  73. Gopi CK. Endomyocardial fibrosis in idiopathic cardiomegaly. Bull WHO. 1968;38:979–91.

    Google Scholar 

  74. Gertz MA, Benson MD, Dyck PI, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66(21):2451–66.

    Article  PubMed  CAS  Google Scholar 

  75. Ghersin E, Lessick J, Litmanovich D, Elhasid R, Lorber A, Dragu R, Rispler S, Haimi M, Engel A. Septal bounce in constrictive pericarditis: diagnosis and dynamic evaluation with multidetector CT. J Comput Assist Tomogr. 2004;28:676–8.

    Article  PubMed  Google Scholar 

  76. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Gulati GS, Sharma S. Pericardial abscess occurring after tuberculous pericarditis: image morphology on computed tomography and magnetic resonance imaging. Clin Radiol. 2004;59:514–9.

    Article  PubMed  CAS  Google Scholar 

  78. Grippon P, Duche M, Aboulker C, Tubiana JM, Levy VG. Syndrome de Budd-Chiari et obstruction membraneuse de Ia veine cava inferieure sus-hepatique. Traitement par angioplastie intraluminale percutanee. Gastroenterol Clin Biol. 1985;9:70–4.

    PubMed  CAS  Google Scholar 

  79. Griffith JF, Mahmoud AE, Cooper S, Elias E, West RJ, Olliff SP. Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol. 1996;51:775–84.

    Article  PubMed  CAS  Google Scholar 

  80. Ganger DR, Klapman JB, McDonald V, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol. 1999;94:603–8.

    PubMed  CAS  Google Scholar 

  81. Holman E, Willet F. Results of radical pericardiectomy for constrictive pericarditis. J Am Med Assoc. 1955;157:789–94.

    Article  PubMed  CAS  Google Scholar 

  82. Hatle LK, Appleton CP, Popp RL. Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography. Circulation. 1989;79:357–70.

    Article  PubMed  CAS  Google Scholar 

  83. Ha JW, Oh JK, Ling LH, Nishimura RA, Seward JB, Tajik AJ. Annulus paradoxus: transmitral flow velocity to mitral annular velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation. 2001;104:976–8.

    Article  PubMed  CAS  Google Scholar 

  84. Ha JW, Oh JK, Ommen SR, Ling LH, Tajik AJ. Diagnostic value of mitral annular velocity for constrictive pericarditis in the absence of respiratory variation in mitral inflow velocity. J Am Soc Echocardiogr. 2002;15:1468–71.

    Article  PubMed  Google Scholar 

  85. Ha JW, Ommen SR, Tajik AJ, Barnes ME, Ammash NM, Gertz MA, Seward JB, Oh JK. Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol. 2004;94:316–9.

    Article  PubMed  Google Scholar 

  86. Habib G, Bucciarelli-Ducci C, Caforio ALP, et al. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by.The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18(10):1090–121.

    Article  PubMed  Google Scholar 

  87. Hoit B, Sahn DJ, Shabetai R. Doppler-detected paradoxus of mitral and tricuspid valve flows in chronic lung disease. J Am Coll Cardiol. 1986;8:706.

    Article  PubMed  CAS  Google Scholar 

  88. Hayashi T, Tsuda E, Kurosaki K, et al. Electrocardiographic and clinical characteristics of idiopathic restrictive cardiomyopathy in children. Circ J. 2007;71(10):1534–9.

    Article  PubMed  Google Scholar 

  89. Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol. 2000;32:574–8.

    Article  PubMed  CAS  Google Scholar 

  90. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology. 1994;106:1042–7.

    Article  PubMed  CAS  Google Scholar 

  91. Harter LP, Gross BH, Hilaire JS, Rilly RA, Goldberg HI. CT and sonographic appearance of hepatic vein obstruction. AJR. 1982;139:176–8.

    Article  PubMed  CAS  Google Scholar 

  92. Hernandez-Guerra M, Lopez E, Bellot P, et al. Systemic haemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology. 2006;43:27–33.

    Article  PubMed  Google Scholar 

  93. Hernandez-Guerra M, Turnes J, Rubinstein P, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology. 2004;40:1197–202.

    Article  PubMed  Google Scholar 

  94. Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg. 1996;171:176–80. discussion 180–171

    Article  PubMed  CAS  Google Scholar 

  95. Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, Leuzzi S, Cecchi E, Trinchero R, Adler Y. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med. 2009;10:217–30.

    Article  Google Scholar 

  96. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010;121:916–28.

    Article  PubMed  Google Scholar 

  97. Imazio M, Spodick DH, Brucato A, Trinchero R, Markel G, Adler Y. Diagnostic issues in the clinical management of pericarditis. Int J Clin Pract. 2010;64:1384–92.

    Article  PubMed  CAS  Google Scholar 

  98. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38:364–71.

    Article  PubMed  Google Scholar 

  99. Jaiyesemi F. Controversies and advances in endomyocardial fibrosis: a review. Afr J Med Sci. 1982;11:37–46.

    Google Scholar 

  100. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000;96:2364–8.

    PubMed  CAS  Google Scholar 

  101. Jeans WD, Bourne JT, Read AE. Treatment of hepatic vein and inferior vena caval obstruction by balloon dilatation. Br J Radiol. 1983;56:687–9.

    Article  PubMed  CAS  Google Scholar 

  102. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial. Eur Respir J. 2008;31(6):1189–96.

    Article  PubMed  CAS  Google Scholar 

  103. Kumar R, Entrikin DW, Ntim WO, Carr JJ, Kincaid EH, Hines MH, Oaks TE, Thohan V, et al. Constrictive pericarditis after cardiac transplantation: a case report and literature review. J Heart Lung Transplant. 2008;27(10):1158–61.

    Article  PubMed  Google Scholar 

  104. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975;54(4):271–99.

    Article  PubMed  CAS  Google Scholar 

  105. Kothari SS, Roy A, Bahl VK. Chronic constrictive pericarditis: pending issues. Ind Heart J. 2003;55(4):1–8.

    Google Scholar 

  106. Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, Hung J, Garcia MJ, Kronzon I, Oh JK, Rodriguez ER, Schaff HV, Schoenhagen P, Tan CD, White RD. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965–1012.e15.

    Article  PubMed  Google Scholar 

  107. Karamitsos TD, Francis JM, Myerson S, et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54(15):1407–24.

    Article  PubMed  Google Scholar 

  108. Kutty VR, Abraham S, Kartha CC. Geographical distribution of endomyocardial fibrosis in south Kerala. Int J Epidemiol. 1996;25(6):1202–7.

    Article  PubMed  CAS  Google Scholar 

  109. Kartha CC. Endomyocardial fibrosis, a case for the tropical doctor. Cardiovasc Res. 1995;30:636–43.

    Article  PubMed  CAS  Google Scholar 

  110. Kisilevsky R. The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000. Amyloid Int J Exp Clin Investig. 2000;7(1):23–5.

    CAS  Google Scholar 

  111. Kristen AV, Siepen F a d, Scherer K, et al. Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging. Amyloid. 2015;22(2):132–41.

    Article  PubMed  Google Scholar 

  112. Kumar S, Dispenzieil A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30(9):989–95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  113. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32(1):45–59.

    PubMed  CAS  Google Scholar 

  114. Kim PN, Mitchell DG, Outwater EK. Budd-Chiari syndrome: hepatic venous obstruction by an elevated diaphragm. Abdom Imaging. 1999;24:267–71.

    Article  PubMed  CAS  Google Scholar 

  115. Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Ind J Gastroenterol. 2005;24:211–5.

    Google Scholar 

  116. Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases. Blood. 2008;111(10):4835–6.

    Article  Google Scholar 

  117. Kubo T, Shibata T, Itoh K, et al. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology. 2006;239:285–90.

    Article  PubMed  Google Scholar 

  118. Kohli V, Pande GK, Dev V, Reddy KS, Kaul U, Nundy S. Management of hepatic venous outflow obstruction. Lancet. 1993;342:718–22.

    Article  PubMed  CAS  Google Scholar 

  119. Khuroo MS, Al-Suhabani H, Al-Sebayel M, et al. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2005;20:1494–502.

    Article  PubMed  Google Scholar 

  120. Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, haemodynamic and histologic studies of the hepatic outflow tract. Am J Med. 1980;68:113–21.

    Article  PubMed  CAS  Google Scholar 

  121. Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, McCormick PA. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2004;19:1135–9.

    Article  PubMed  Google Scholar 

  122. Kondur AK, Li T, Vaitkevicius P, et al. Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin Cardiol. 2009;32(6):E55–9.

    Article  PubMed  Google Scholar 

  123. Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, Michaud GF, Tedrow UB, Stevenson WG. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87–93. https://doi.org/10.1161/CIRCEP.114.002145.

    Article  PubMed  Google Scholar 

  124. Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietila-Effati P, Utrianen S, Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624–32.

    Article  PubMed  Google Scholar 

  125. Ling LH, Oh JK, Breen JF, Schaff JV, Danielson GK, Mahoney DW, Seward JB, Tajik AJ. Calcific constrictive pericarditis: is it still with us? Ann Intern Med. 2000;132:444–50.

    Article  PubMed  CAS  Google Scholar 

  126. Ludwig J, Hashimoto E, McGill D, Heerden JV. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc. 1990;65:51–5.

    Article  PubMed  CAS  Google Scholar 

  127. Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney OW, Seward JB, Tajik JA. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380–6.

    Article  PubMed  CAS  Google Scholar 

  128. Levine HD. Myocardial fibrosis in constrictive pericarditis electrocardiographic and pathologic observations. Circulation. 1973;48:1268–81.

    Article  PubMed  CAS  Google Scholar 

  129. Lisbona A, Katz S, Mishkin S. Serial radionuclide liver imaging in Budd-Chiari syndrome. J Can Assoc Radiol. 1981;32:175–7.

    PubMed  CAS  Google Scholar 

  130. Lee BB, Villavicencio L, Kim YW, et al. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg. 2006;43:101–8.

    Article  PubMed  Google Scholar 

  131. Langlet P, Valla D. Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome? Acta Gastroenterol Belg. 2002;65:155–60.

    PubMed  Google Scholar 

  132. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003;39:496–501.

    Article  PubMed  Google Scholar 

  133. Liang JJ, Hebl VB, DeSimone CV, Madhavan M, Nanda S, Kapa S, Maleszewski JJ, Edwards WD, Reeder G, Cooper LT, Asirvatham SJ. Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail. 2014;2:466–73. https://doi.org/10.1016/j.jchf.2014.03.015.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Lu Y, Grant C, Xie K, Sweiss NJ. Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high protein, and very low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. Clin Nucl Med. 2017;2(2):88–94.

    Article  Google Scholar 

  135. McDermott WV, Stone MD, Bothe A, Trey C. Budd-Chiari syndrome: historical and clinical review with analysis of surgical corrective procedures. Am J Surg. 1984;147:463–7.

    Article  PubMed  CAS  Google Scholar 

  136. Menu Y, Alison D, Lorphelin JM, Valla D, Belghiti J, Nahum H. Budd-Chiari syndrome: US evaluation. Radiology. 1985;157:761–4.

    Article  PubMed  CAS  Google Scholar 

  137. Metras D. Endomyocardial fibrosis and its surgical treatment: Ivory Coast experience. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. New Delhi: Oxford University Press; 1993. p. 207–19.

    Google Scholar 

  138. Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):819–37.

    Article  PubMed  CAS  Google Scholar 

  139. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocard. 2011;12(3):167–205.

    Article  Google Scholar 

  140. MacGregor JH, Chen JT, Chiles C, Kier R, Godwin JD, Ravin CE. The radiographic distinction between pericardial and myocardial calcifications. Am J Roentgenol. 1987;148(4):675–7.

    Article  CAS  Google Scholar 

  141. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH, Priori SG, Alonso Garcia MA. Guidelines on the diagnosis and management of pericardial diseases executive summary: the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004;25(7):587–610.

    Article  PubMed  Google Scholar 

  142. McCaughan BC, Schaff HV, Piehler JM, Danielson GK, Orszulak TA, Puga FJ, Pluth JR, Connolly DC, McGoon DC. Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg. 1985;89(3):340–50.

    Article  PubMed  CAS  Google Scholar 

  143. Mocumbi AO, Ferreira MB, Sidi D, et al. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008;359(1):43–9.

    Article  PubMed  CAS  Google Scholar 

  144. Mady C, Barreto ACP, de Oliveira SA, et al. Effectiveness of operative and non-operative therapy in endomyocardial fibrosis. Am J Cardiol. 1989;63:1281–2.

    Article  PubMed  CAS  Google Scholar 

  145. Mullen DC, Dillon ML, Young WG, Sealy WC. Pericardiectomy in nontuberculous pericarditis. J Thorac Cardiovasc Surg. 1969;58:517.

    Article  PubMed  CAS  Google Scholar 

  146. Makuuchi M, Hasegawa H, Yamazaki S, et al. Primary Budd- Chiari syndrome: ultrasonic demonstration. Radiology. 1984;1(52):775–9.

    Article  Google Scholar 

  147. Mehrotra G, Singh RP, Krishna A, Singh BK. Pyogenic liver abscess causing acute Budd-Chiari syndrome. Ann Trop Paediatr. 1992;12:451–3.

    Article  PubMed  CAS  Google Scholar 

  148. Markert DJ, Shanmuganathan K, Mirvis SE, Nakajima Y, Hayakawa M. Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma. Clin Radiol. 1997;52:384–7.

    Article  PubMed  CAS  Google Scholar 

  149. Mettler F. Essentials of nuclear medicine imaging. Orlando: Grune and Stratton; 1983. p. 196.

    Google Scholar 

  150. Moss AA, Gamsu G, Genant HK. Computed tomogrpahy of the body. Philadelphia: Saunders; 1983. p. 687–8.

    Google Scholar 

  151. Murphy FB, Steinberg HV, Shires GT, Martin LG, Bernardino ME. The Budd-Chiari syndrome: a review. AJR. 1986;147:9–15.

    Article  PubMed  CAS  Google Scholar 

  152. Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39:500–8.

    Article  Google Scholar 

  153. Murad SD, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83–90.

    Article  Google Scholar 

  154. Martin LG, Henderson JM, Millikan WJ, Casarella WJ, Kaufman SL. Angioplasty for long-term treatment of patients with Budd-Chiari syndrome. Am J Roentgenol. 1990;154:1007–10.

    Article  CAS  Google Scholar 

  155. Mishra TK, Routray SN, Behera M, Patnaik UK, Satapathy C. Percutaneous balloon angioplasty of membranous obstruction of the inferior vena cava. Indian Heart J. 2003;55:362–4.

    PubMed  CAS  Google Scholar 

  156. McMullin MF, Hillmen P, Jackson J. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med. 1994;235:85–9.

    Article  PubMed  CAS  Google Scholar 

  157. Molmenti EP, Segev DL, Arepally A, et al. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg. 2005;241:978–81.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Meier WL III, WaIler RM III, Sones PJ Jr. Budd-Chiari web treated by percutaneous transluminal angioplasty. AJR. 1981;137:1257–8.

    Article  PubMed  Google Scholar 

  159. Muller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J. 1999;14(5):1117–22.

    Article  PubMed  CAS  Google Scholar 

  160. Merlini G. AL amyloidosis: from molecular mechanisms to targeted therapies. Hematol Am Soc Hematol Educ Program. 2017;2017(1):1–12.

    Article  Google Scholar 

  161. Nagueh SF, Kopelen HA, Zoghbi WA. Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function. Circulation. 1996;93(6):1160–9.

    Article  PubMed  CAS  Google Scholar 

  162. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quiñones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia: a new application of tissue Doppler imaging. Circulation. 1998;98(16):1644–50.

    Article  PubMed  CAS  Google Scholar 

  163. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH III, Zoghbi WA, Quinones MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999;99(2):254–61.

    Article  PubMed  CAS  Google Scholar 

  164. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30(6):1527–33.

    Article  PubMed  CAS  Google Scholar 

  165. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.

    Article  PubMed  Google Scholar 

  166. Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Haemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol. 2001;37(1):278–85.

    Article  PubMed  CAS  Google Scholar 

  167. Nair RR, Gupta PN, Valiathan MS, Kartha CC, Eapen JT, Nair NG. Enhanced cerium concentration in magnesium deficient plants. Curr Sci. 1989;58:696–7.

    CAS  Google Scholar 

  168. Namboodiri N, Stiles MK, Young GD, et al. Electrophysiological features of atrial flutter in cardiac sarcoidosis: a report of two cases. Ind Pac Electrophysiol J. 2012;12(6):284–9.

    Article  Google Scholar 

  169. Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestion of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875–81.

    Article  PubMed  Google Scholar 

  170. Nagai S, Yokomatsu T, Tanizawa K, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med. 2014;53(23):2761.

    Article  PubMed  Google Scholar 

  171. Nery PB, McArdle BA, Redpath CI, et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2014;37(3):364–74.

    Article  PubMed  Google Scholar 

  172. Nishikawa M, Miyoshi S, Imai Y, et al. Treatment of the Budd- Chiari syndrome in polycythemia vera by repeated percutaneous transluminal angioplasty of a hepatic vein stenosis. Postgrad Med J. 1982;58:511–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  173. Nunez O, de la Cruz G, Molina J, et al. Interventional radiology, angioplasty and TIPS in Budd-Chiari syndrome. Gastroenterol Hepatol. 2003;26:461–4.

    PubMed  CAS  Google Scholar 

  174. Niederau CL, Fischer RU, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110(4):1107–19.

    Google Scholar 

  175. Olsen EGJ. Morphological overview and pathogenetic mechanism in endomyocardial fibrosis associated with eosinophilia. In: Olsen EGJ, Sekiguchi M, editors. Cardiomyopathy update3. Tokyo: University of Tokyo Press; 1990. p. 1–8.

    Google Scholar 

  176. Oh JK, Hatle LK, Mulvagh SL, Tajik AJ. Transient constrictive pericarditis: diagnosis by two-dimensional Doppler echocardiography. Mayo Clin Proc. 1993;68(12):1158–64.

    Article  PubMed  CAS  Google Scholar 

  177. de Oliveira SA, Barretto ACP, Mady C, et al. Surgical treatment ofendomyocardial fibrosis: a new approach. J Am Call Cardiol. 1990;16:1246–51.

    Article  Google Scholar 

  178. Olsen EGJ, Spry CJF. The pathogenesis of Loeffler’s endomyocardial disease and its relationship to endomyocardial fibrosis. In: Yu P, Goodwin JF, editors. Progress in cardiology, vol. 8. Philadelphia: Lea & Febiger; 1979. p. 281–303.

    Google Scholar 

  179. Ohno S, Yoshimoto M, Honda S, et al. The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo models. J Immunol. 2002;169(7):4039–45.

    Article  PubMed  CAS  Google Scholar 

  180. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis. 2002;22:15–26.

    Article  PubMed  Google Scholar 

  181. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis. 2008;28(3):259–69.

    Article  PubMed  Google Scholar 

  182. Primignani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006;44:1528–34.

    Article  PubMed  CAS  Google Scholar 

  183. Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006;130:2031–8.

    Article  PubMed  CAS  Google Scholar 

  184. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44(5):1308–16.

    Article  PubMed  Google Scholar 

  185. Pelage JP, Denys A, Valla D, et al. Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol. 2003;13:286–93.

    Article  PubMed  Google Scholar 

  186. Panis Y, Belghiti J, Valla D, Benhamou JP, Fekete F. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery. 1994;115:276–81.

    PubMed  CAS  Google Scholar 

  187. Perello A, Garcia-Pagan JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132–9.

    Article  PubMed  Google Scholar 

  188. Qiao T, Liu CJ, Liu C, Chen K, Zhang XB, Zu MH. Interventional endovascular treatment for Budd-Chiari syndrome with long-term follow-up. Swiss Med Wkly. 2005;135:318–26.

    PubMed  Google Scholar 

  189. Reuss CS, Wilansky SM, Lester SJ, Lusk JL, Grill DE, Oh JK, et al. Using mitral ‘annulus reversus’ to diagnose constrictive pericarditis. Eur J Echocardiogr. 2009;10:372–5.

    Article  PubMed  Google Scholar 

  190. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012;126(10):1286–300.

    Article  PubMed  PubMed Central  Google Scholar 

  191. Reisinger J, Dubrey SW, Lavalley M, et al. Electrophysiologic abnormalities in AL (Primary) amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997;30(4):1046–51.

    Article  PubMed  CAS  Google Scholar 

  192. Ryu RK, Durham JD, Krysl J, et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol. 1999;10:799–805.

    Article  PubMed  CAS  Google Scholar 

  193. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery. 2004;135:394–403.

    Article  PubMed  Google Scholar 

  194. Roukoz H, Shah M, Masilamani LJ, et al. fQRS as a marker of granulomatous disease in patients presenting with ventricular tachycardia and normal left ventricular ejection fraction. Indian Heart J. 2015;67(3):222–6.

    Article  PubMed  PubMed Central  Google Scholar 

  195. Roberts JT, Beck CS. The effect of chronic cardiac compression on the size of the heart muscle fibers. Am Heart J. 1941;22:314–20.

    Article  Google Scholar 

  196. Rangheard AS, Vilgrain V, Audet P, et al. Focal nodular hyperplasia inducing hepatic vein obstruction. AJR Am J Roentgenol. 2002;179:759–62.

    Article  PubMed  Google Scholar 

  197. Rahhal RM, Pashankar DS, Bishop WP. Ulcerative colitis complicated by ischemic colitis and Budd-Chiari syndrome. J Pediatr Gastroenterol Nutr. 2005;40:94–7.

    Article  PubMed  Google Scholar 

  198. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63:86–108.

    Article  PubMed  CAS  Google Scholar 

  199. Shaper AG. Cardiovascular disease in the tropics. II Endomyocardial fibrosis. BMJ. 1972;3:743–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  200. Shaper AG. The aetiology of endomyocardial fibrosis. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. New Delhi: Oxford University Press; 1993. p. 111–20.

    Google Scholar 

  201. Shrestha SM, Okuda K, Uchida T, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11:170–9.

    Article  PubMed  CAS  Google Scholar 

  202. Sengupta P, Eleid MF, Sundt TM. Regional variability of pericardial thickness influences left ventricular diastolic recoil mechanics in constrictive pericarditis. J Am Soc Echocardiogr. 2008;21:518.

    Google Scholar 

  203. Sengupta PP, Eleid MF, Khandheria BK. Constrictive pericarditis. Circ J. 2008;72:1555–62.

    Article  PubMed  Google Scholar 

  204. Sengupta PP, Khandheria BK, Korinek J, Wang J, Jahangir A, Seward JB, et al. Apex-to-base dispersion in regional timing of left ventricular shortening and lengthening. J Am Coll Cardiol. 2006;47:163–72.

    Article  PubMed  Google Scholar 

  205. Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, et al. Disparate patterns ofleft ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. JACC Cardiovasc Imaging. 2008;1(1):29–38.

    Article  PubMed  Google Scholar 

  206. Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, Korinek J, Belohlavek M, Sundt TM 3rd, et al. Comparison of usefulness of tissue Doppler imaging versus brain natriuretic peptide for differentiation of constrictive pericardial disease from restrictive cardiomyopathy. Am J Cardiol. 2008;102:357.

    Article  PubMed  CAS  Google Scholar 

  207. Sengupta PP, Mohan JC, Mehta V, Arora R, Khandheria BK, Pandian NG. Doppler tissue imaging improves assessment of abnormal interventricular septal and posterior wall motion in constrictive pericarditis. J Am Soc Echocardiogr. 2005;18:226–30.

    Article  PubMed  Google Scholar 

  208. Sengupta PP, Mohan JC, Mehta V, Arora R, Pandian NG, Khandheria BK. Accuracy and pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis by tissue Doppler imaging. Am J Cardiol. 2004;93:886–90.

    Article  PubMed  Google Scholar 

  209. Sengupta PP, Mohan JC, Mehta V, Jain V, Arora R, Pandian NG, et al. Comparison of echocardiographic features of noncompaction of the left ventricle in adults versus idiopathic dilated cardiomyopathy in adults. Am J Cardiol. 2004;94:389–91.

    Article  PubMed  Google Scholar 

  210. Sengupta PP, Tajik AJ, Chandrasekaran K, Khandheria BK. Twist mechanics of the left ventricle: principles and application. JACC Cardiovasc Imaging. 2008;1:366–76.

    Article  PubMed  Google Scholar 

  211. Sankhyan LK, Yadav V, Sharma S, Choubey M, George N, Sushamagayatri B, Malik V, Chowdhury UK. Assessment of myocardial mechanics in patients undergoing pericardiectomy for chronic constrictive pericarditis by tissue doppler imaging and 2D speckled tracking echocardiography: a prospective observational (Cohort) study. J Clin Cardiol Cardiovasc Interv. 2021;4(3) https://doi.org/10.31579/2641-0419/115.

  212. Shabetai R, Fowler NO, Guntheroth WG. The haemodynamics of cardiac tamponade and constrictive pericarditis. Am J Cardiol. 1970;26:480–9.

    Article  PubMed  CAS  Google Scholar 

  213. Shabetai R, Mangiardi L, Bhargava A, Ross J Jr, Higgins CB. The pericardium and cardiac function. Prog Cardiovasc Dis. 1979;22:107–34.

    Article  PubMed  CAS  Google Scholar 

  214. Shabetai R. Controversial issues in restrictive cardiomyopathy. Postgrad Med J. 1992;68:S47–51.

    PubMed  Google Scholar 

  215. Shabetai R. Left ventricular function and myocardial contractility in chronic constrictive pericarditis. Chest. 1971;59:476–7.

    Article  PubMed  CAS  Google Scholar 

  216. Shabetai R. Pathophysiology and differential diagnosis of restrictive cardiomyopathy. Cardiovasc Clin. 1988;19:123–32.

    PubMed  CAS  Google Scholar 

  217. Samuel I, Anklesaria X. Endomyocardial fibrosis in South India. Ind J Path Bact. 1960;3:157.

    Google Scholar 

  218. Schwefer M, Aschenbach R, Heidemann J, Mey C, Lapp H. Constrictive pericarditis, still a diagnostic challenge: Comprehensivereview of clinical management. Eur J Cardiothorac Surg. 2009;36:502–10.

    Article  PubMed  Google Scholar 

  219. Shapru RP. Clinical profile of EMG. ICMR workshop proceedings, 1981. In: Shapru RP, editor. EMG in India. Indian Council of Medical Research; 1983.

    Google Scholar 

  220. Shivakumar K, Appukuttan PS, Cc K. Interactions of thorium and cerium with adenine nucleotides. Biochem lnt. 1989;19:845–53.

    CAS  Google Scholar 

  221. Shivakumar K, Nair RR, Valiathan MS. Paradoxical effect of cerium on collagen synthesis in cardiac fibroblasts. J Mol Cell Cardiol. 1992;24:775–80.

    Article  PubMed  CAS  Google Scholar 

  222. Seth S, Thatai D, Sharma S, et al. Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India. Eur J Heart Fail. 2004;6(6):723–9.

    Article  PubMed  Google Scholar 

  223. Sasidharan K, Balakrishnan KG, Venkitachalam CG, Sapru RP. Radiological features of endomyocardial fibrosis. Indian Heart J. 1980;32:234.

    Google Scholar 

  224. Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130(2–3):88–98.

    Article  PubMed  CAS  Google Scholar 

  225. Sousa M, Monohan G, Rajagopalan N, et al. Heart transplantation in cardiac amyloidosis. Heart Fail Rev. 2017;22(3):317–27.

    Article  PubMed  Google Scholar 

  226. Sachithanantham S, Wechalekar AD. Imaging in systemic amyloidosis. Br Med Bull. 2013;107:41–56.

    Article  Google Scholar 

  227. Schwartz DJ, Thanavaro S, Kieiger RE, Krone RJ, Connors SP, Oliver CG. Epicardial pacemaker complicated by cardiac tamponade and constrictive pericarditis. Chest. 1979;76:226–7.

    Article  PubMed  CAS  Google Scholar 

  228. Stollberger C, Finsterer J. Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy. Clin Cardiol. 2007;30(8):375–80.

    Article  PubMed  PubMed Central  Google Scholar 

  229. Srivastava PM, Burrell LM, Calafiore P. Lateral vs medial mitral annular tissue Doppler in the echocardiographic assessment of diastolic function and filling pressures: which should we use? Eur J Echocardiogr. 2005;6:97–106.

    Article  PubMed  Google Scholar 

  230. Scholtz W, et al. Severe calcification of the latral mitral annulus in constrictive pericarditis: a potential pitfall for the use of echocardiographic tissue Doppler imaging. Eur J Echocardiogr. 2008;9:403–5.

    PubMed  Google Scholar 

  231. Sousa M, Manohan G, Rajagopalan N, et al. Heart treatment in cardiac amyloidosis. Heart Fail Rev. 2017;22(3):317–27.

    Article  PubMed  Google Scholar 

  232. Sato M, Yamada R, Tsuji K, et al. Percutaneous transluminal angioplasty in segmental obstruction of the hepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol. 1990;13:189–92.

    Article  PubMed  CAS  Google Scholar 

  233. Safka V, Hulek P, Krajina A, et al. Budd-Chiari syndrome and TIPS-twelve years’ experience. Cas Lek Cesk. 2005;144(Suppl 3):38–42.

    PubMed  Google Scholar 

  234. Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP. Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol. 2004;40:172–80.

    Article  PubMed  CAS  Google Scholar 

  235. Srivatsa UN, Rogers J. Sarcoidosis and atrial fibrillation: a rare association and interlink with inflammation. Indian Pacing Electrophysiol J. 2012;12(6):290–1.

    Article  PubMed  PubMed Central  Google Scholar 

  236. Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg. 2001;233:522–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  237. Schoenfeld MH, Edwards WS, William GD Jr, et al. Restrictive cardiomyopathy versus constrictive pericarditis-role of endomyocardial biopsy in avoiding unnecessary thoracotomy. Circulation. 1987;75:1012–7.

    Article  PubMed  CAS  Google Scholar 

  238. Tharakan JA. Electrocardiography in endomyocardial fibrosis. Indian Pacing Electrophysiol J. 2011;11:129–33.

    PubMed  PubMed Central  Google Scholar 

  239. Tei C, Child JS, Tanaka H, Shah PM. Atrial systolic notch on the interventricular septal echogram: an echocardiographic sign of constrictive pericarditis. J Am Coll Cardiol. 1983;1(3):907–12.

    Article  PubMed  CAS  Google Scholar 

  240. Talreja DR, Edwards WD, Danielson GK, Schaff HV, Tajik AJ, Tazelaar HD, Breen JF, Oh JK. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852–7.

    Article  PubMed  Google Scholar 

  241. Tharakan JM, Venkatachalam CG, Balakrishnan KG. Angiographic features of endomyocardial fibrosis. In: Valiathan MS, editor. Endomyocardial Fibrosis. New Delhi: Oxford University Press; 1993. p. 168–84.

    Google Scholar 

  242. Talwar KK, Kumar V, Chopra P, et al. Endomyocardial biopsy study in patients with restrictive cardiomyopathy. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. New Delhi: Oxford University Press; 1993. p. 185–94.

    Google Scholar 

  243. Talwar KK, Narula JP, Chopra P. Myocarditis and myocardial interstitial fibrosis in constrictive pericarditis-an extended pathological spectrum. Int J Cardio1. 1990;29(2):241–3.

    Article  CAS  Google Scholar 

  244. Tang TJ, Batts KP, de Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001;35:338–43.

    Article  PubMed  CAS  Google Scholar 

  245. Tavora F, Creswell N, Li L, et al. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol. 2009;104:571–7.

    Article  PubMed  Google Scholar 

  246. Thachil A, Reddy S, Rao HB, et al. Subtle electrocardiographic findings in idiopathic ventricular tachycardia- a malignant subset. Heart Rhythm. 2010;7(5):S196–257.

    Google Scholar 

  247. Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography. J Card Fail. 2015;21:313–22.

    Article  PubMed  Google Scholar 

  248. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. CT of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10:47–50.

    Article  PubMed  CAS  Google Scholar 

  249. Taguchi M, Ito Y, Shinohara S, et al. Successful management of BCS with PTA. Rinsho Hoshasen. 1983;28:615–7.

    PubMed  CAS  Google Scholar 

  250. Tavill AS, Wood EJ, Kreel L, Jones EA, Gregory M, Sherlock S. The Budd-Chiari syndrome: Correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology. 1975;68:509–18.

    Article  PubMed  CAS  Google Scholar 

  251. Tisnado J, Cho SR, Carithers J, Goldschmidt RA, Vines FS, Amendola M. The Budd-Chiari syndrome: angiographic pathologic correlation. Radiographics. 1983;3:155–83.

    Article  Google Scholar 

  252. Tyagi S, Jain BL, Kumar N, Lahoti D, Arora R. Balloon dilatation of inferior vena cava stenosis in Budd-Chiari syndrome. J Assoc Physicians India. 1996;44:378–80.

    PubMed  CAS  Google Scholar 

  253. Uddin W, Ramage JK, Portmann B, et al. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut. 1995;36:142–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  254. Valiathan MS, Balakrishnan KG, Kartha CC. Endomyocardial fibrosis. In: Ahuja MMS, editor. Advances in clinical medicine. New Delhi: Churchill Livingstone; 1991. p. 125–43.

    Google Scholar 

  255. Valiathan MS, Shyamkrishnan KG. Surgical treatment of endomyocardial fibrosis: Kerala experience. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial fibrosis. New Delhi: Oxford University Press; 1993. p. 220–07.

    Google Scholar 

  256. Valla D. Hepatic venous outflow tract obstruction etipathogenesis: Asia versus the West. J Gastroenterol Hepatol. 2004;19:S204–11.

    Article  Google Scholar 

  257. Voelkel AG, Pietro DA, Folland ED, Fisher ML, Parisi AF. Echocardiographic features of constrictive pericarditis. Circulation. 1978;58:871–5.

    Article  PubMed  CAS  Google Scholar 

  258. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002;22:5–14.

    Article  PubMed  Google Scholar 

  259. Veress G, Ling LH, Kim KH, Dal-Bianco JP, Schaff HV, Espinosa RE, Melduni RM, Tajik JA, Sundt TM 3rd, Oh JK. Mitral and tricuspid annular velocities before and after pericardiectomy in patients with constrictive pericarditis. Circ Cardiovasc Imaging. 2011;4:399–407.

    Article  PubMed  Google Scholar 

  260. Verhaert D, Gabriel RS, Johnston D, Lytle BW, Desai MY, Klein AL. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging. 2010;3:333–43.

    Article  PubMed  Google Scholar 

  261. Von Bibra H, Schober K, Jenni R, Busch R, Sebening H, Blomer H. Diagnosis of constrictive pericarditis by pulsed Doppler echocardiography of the hepatic vein. Am J Cardiol. 1989;63:483–8.

    Article  Google Scholar 

  262. Valiathan MS, Kartha CC. Endomyocardial fibrosis-The possible connexion with myocardial levels of magnesium and cerium. Int J Cardiol. 1990;28:1–5.

    Article  PubMed  CAS  Google Scholar 

  263. Valiathan MS, Kartha CC, Eapen JT, Dang HS, Sunta CM. A geochemical basis for endomyocardial fibrosis. Cardiovasc Res. 1989;23:647–8.

    Article  PubMed  CAS  Google Scholar 

  264. Venkatachalam CG, Balakrishanan KG, Tharakan JM. Echocardiographic findings in endomyocardial fibrosis. In: Valiathan MS, editor. Endomyocardial fibrosis. New Delhi: Oxford University Press; 1993. p. 153–67.

    Google Scholar 

  265. Vita T, Okada DR, Veillet-Chowdhury M, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11(1):e007030.

    Article  PubMed  PubMed Central  Google Scholar 

  266. Valla DC. Prognosis in Budd Chiari syndrome after reestablishing hepatic venous drainage. Gut. 2006;55:761–3.

    Article  PubMed  PubMed Central  Google Scholar 

  267. Valla D, Hadengue A, el Younsi M, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology. 1997;25:814–9.

    Article  PubMed  CAS  Google Scholar 

  268. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology. 1986;90:807–11.

    Article  PubMed  CAS  Google Scholar 

  269. Westermark P, Benson MD, Buxbaum IN, et al. A primer of amyloid nomenclature. Amyloid Int J Exp Clin Invest. 2007;14(3):179–83.

    CAS  Google Scholar 

  270. Wechalekar AD, Schonland SO, Kastritis E, et al. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood. 2013;121(17):3420–7.

    Article  PubMed  CAS  Google Scholar 

  271. Wechalekar AD, Whelan C. Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis. Blood Cancer J. 2017;7(3):e546.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  272. Witte AM, Kool LJ, Veenendaal R, Lamers CB, van Hoek B. Hepatic vein stenting for Budd-Chiari syndrome. Am J Gastroenterol. 1997;92:498–501.

    PubMed  CAS  Google Scholar 

  273. Wu T, Wang L, Xiao Q, et al. Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome- R1. Int J Cardiol. 2002;83:175–8.

    Article  PubMed  Google Scholar 

  274. Wang SL, Sze DY, Busque S, et al. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Radiology. 2005;236:352–9.

    Article  PubMed  Google Scholar 

  275. Xiaoming Z, Zhonggao W. Interventional or semi-interventional treatment for Budd-Chiari syndrome. Chin Med Sci J. 2003;18:111–5.

    PubMed  Google Scholar 

  276. Xu K, Feng B, Zhong H, et al. Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J. 2003;116:609–15.

    PubMed  Google Scholar 

  277. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006–10.

    Article  PubMed  CAS  Google Scholar 

  278. Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16(2):140–7.

    Article  PubMed  PubMed Central  Google Scholar 

  279. Young ID, Clark RN, Manley PN, Groll A, Simon JB. Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. Gastroenterology. 1988;94:503–7.

    Article  PubMed  CAS  Google Scholar 

  280. Young JB, Leon CA, Short HD, Noon JP, Lawrence EC, Whisennand HH, et al. Evolution of haemodynamics after orthotopic heart and heart-lung transplantation: Early restrictive patterns persisting in occult fashion. J Heart Transplant. 1987;6:34–43.

    PubMed  CAS  Google Scholar 

  281. Yang XL, Cheng TO, Chen CR. Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol. 1996;28:1720–4.

    Article  PubMed  CAS  Google Scholar 

  282. Yamada A, Sato M, Kawabata M, Nakatsuka H, Nakamure K, Kobayashi N. Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. Radiology. 1983;1(49):91–6.

    Article  Google Scholar 

  283. Yamada A, Tsumura M, Itami M, et al. Nonsurgically treated long segmental obstruction of the hepatic IVC by means of TA using Gruentzig balloon catheter. Nippon Igaku Hoshasen Gakkai Zasshi. 1981;41:101–7.

    PubMed  CAS  Google Scholar 

  284. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Kobayashi N. Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. Radiology. 1983;149:91–6.

    Article  PubMed  CAS  Google Scholar 

  285. Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging. 2011;4:1180–91.

    Article  PubMed  Google Scholar 

  286. Zylberberg H, Valla D, Viguie F, Casadevall N. Budd-Chiari syndrome associated with 5q deletion and hypereosinophilia. J Clin Gastroenterol. 1996;23:66–8.

    Article  PubMed  CAS  Google Scholar 

  287. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30:84–9.

    Article  PubMed  CAS  Google Scholar 

  288. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol. 2003;9:2587–91.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Cardiothoracic Surgery, All India Institute of Medical Sciences, New Delhi, Delhi, India

    Ujjwal K. Chowdhury

  2. Department of Cardiothoracic Surgery, All India Institute of Medical Sciences, New Delhi, Delhi, India

    Lakshmi Kumari Sankhyan

Authors
  1. Ujjwal K. Chowdhury
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lakshmi Kumari Sankhyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chowdhury, U.K., Sankhyan, L.K. (2023). Diseases Mimicking Constrictive Pericarditis: Salient Features and Novel Strategies of Management. In: Surgical Treatment of Chronic Constrictive Pericarditis. Springer, Singapore. https://doi.org/10.1007/978-981-99-5808-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-5808-5_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-5807-8

  • Online ISBN: 978-981-99-5808-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation